Byrne Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
CIM
GI
EFG
LHWM
FFA
VCM
MGI
CI
MPWT
CA
Byrne Asset Management's CRL Position: Q3 2026 in Review
Byrne Asset Management held its Charles River Laboratories (CRL) position steady in Q3 2026 at 28 shares worth $8.03K. The position accounts for ﹤0.01% of the portfolio, ranked #464.
Byrne Asset Management first reported a position in CRL in Q4 2021 and has held it in 20 quarters since. The position peaked at $458K in Q4 2021. 15 funds tracked by Wall St. Rank hold CRL as of Q3 2026.
- Byrne Asset Management held 28 shares of Charles River Laboratories worth $8.03K as of Q3 2026.
- Byrne Asset Management left its Charles River Laboratories share count unchanged in Q3 2026.
- Charles River Laboratories made up ﹤0.01% of Byrne Asset Management's portfolio in Q3 2026, its #464 holding.
- Byrne Asset Management first reported a position in Charles River Laboratories in Q4 2021 and has held it in 20 quarters since.
- Byrne Asset Management's Charles River Laboratories position peaked at $458K in Q4 2021.
- 15 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.
Based on Byrne Asset Management's 13F filing for Q3 2026, filed 6 Oct 2026.